| Trial ID: | L2224 |
| Source ID: | NCT00700830
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
|
| Acronym: |
IDEALS
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Assessment the incidence of the Serious Adverse Events including the major Hypoglycaemia., During study | Secondary: HbA1c, after 12 weeks (3 months) AND after 24 weeks (6 months)|FBG (Fasting Blood Glucose), Monthly average for each month, and average of the past quarter|Weight, after 12 weeks (3 months) AND after 24 weeks (6 months)
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1976
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-01
|
| Completion Date: |
2009-09
|
| Results First Posted: |
|
| Last Update Posted: |
2014-08-15
|
| Locations: |
Algiers, 16035, Algeria
|
| URL: |
https://clinicaltrials.gov/show/NCT00700830
|
